Wilke, for instance, is the principal investigator for a breast cancer vaccine trial she’s running with colleagues from the University of Wisconsin School of Medicine and Public Health in Madison. The team is testing whether people who have received treatment for triple-negative breast cancer — a particularly aggressive form of the disease — respond to a DNA-based vaccine that could boost their immune systems and prevent reoccurrence.
University Communications